Invivo Therapeutics (NVIV) Tops Q3 EPS by 2c
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Invivo Therapeutics (NASDAQ: NVIV) reported Q3 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Invivo Therapeutics (NVIV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AK Steel (AKS) Pares Earlier Gains, Shares Whipsaw
- AVX Corp. (AVX) Tops Q3 EPS by 1c
- Waters Corp. (WAT) Tops Q4 EPS by 8c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!